SRF
- P/E
- 33.71
Key Fundamentals
MidcapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 14.60%
- Debt to Equity
- 0.36
- EPS (TTM)
- ₹72.93
- Book Value
- ₹516.26
- Market Cap
- —
- P/E (TTM)
- 33.71
- P/B
- 4.76
- ROE
- 14.30%
- Dividend Yield
- 0.21%
- EBITDA
- ₹3,517 Cr
- 52W High
- ₹3,143.00
- 52W Low
- ₹2,178.30
- Volume
- 0
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 58
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 45
- Weak
- Cheap vs sector & own history 24% weight
- Growth
- 50
- Average
- Sales & profit trajectory 9% weight
- Financial Health
- 51
- Average
- Solvency, leverage, coverage 9% weight
- Momentum
- 26
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 44
- Weak
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
No strengths listed
Weaknesses
3- Stock is trading at 5.09 times its book value
- Company has a low return on equity of 12.4% over last 3 years.
- Company might be capitalizing the interest cost
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 10 | 3 | 6 |
| Oscillators | Bearish | 4 | 3 | 2 |
| Moving Averages | Strong Bearish | 6 | 0 | 4 |
Oscillators
Bearish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 54.08
- Neutral
- MACD (12,26,9)
- −27.79
- Bullish
- SMA (50)
- 2,484.53
- Bearish
- SMA (200)
- 2,624.43
- Bearish
As of
Analyst Rating
18 of 29 analysts rate Buy, 5 Hold, 6 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +13.14% |
|---|---|
| 5Y | +13.45% |
| 3Y | +2.01% |
| 1Y | +7.45% |
| TTM | +12.99% |
Net profit
| 10Y | +15.62% |
|---|---|
| 5Y | +8.90% |
| 3Y | −5.32% |
| 1Y | +46.68% |
| TTM | +51.19% |
Operating cash flow
| 10Y | +8.89% |
|---|---|
| 5Y | +7.58% |
| 3Y | −4.17% |
| 1Y | +2.69% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +0.63 pp |
|---|---|
| 5Y | −3.79 pp |
| 3Y | −2.13 pp |
| 1Y | +3.10 pp |
| TTM | +2.88 pp |
Revenue by year
| Mar 2017 | ₹4,822 Cr |
|---|---|
| Mar 2018 | ₹5,589 Cr |
| Mar 2019 | ₹7,100 Cr |
| Mar 2020 | ₹7,209 Cr |
| Mar 2021 | ₹8,400 Cr |
| Mar 2022 | ₹12,434 Cr |
| Mar 2023 | ₹14,870 Cr |
| Mar 2024 | ₹13,139 Cr |
| Mar 2025 | ₹14,693 Cr |
| Mar 2026 | ₹15,787 Cr |
Net profit by year
| Mar 2017 | ₹515 Cr |
|---|---|
| Mar 2018 | ₹462 Cr |
| Mar 2019 | ₹642 Cr |
| Mar 2020 | ₹1,019 Cr |
| Mar 2021 | ₹1,198 Cr |
| Mar 2022 | ₹1,889 Cr |
| Mar 2023 | ₹2,162 Cr |
| Mar 2024 | ₹1,336 Cr |
| Mar 2025 | ₹1,251 Cr |
| Mar 2026 | ₹1,835 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
SRF Ltd trades at ₹2,358.6 as of 2026-10-29 with a market cap of ₹69,914.76 Cr. The company shows a TTM profit growth of 57% and a 10-year sales CAGR of 13%, though its 3-year ROE of 12% remains below its longer-term average and the stock trades at a P/B of 4.57. The stock is down 23% over the past year and sits 25% below its 52-week high of ₹3,143.
- TTM profit growth of 57% signals a strong earnings recovery after a weak 3-year CAGR of -4%, suggesting the trough in the chemicals cycle may be behind
- 10-year compounded sales CAGR of 13% and profit CAGR of 16% demonstrate a consistent long-term growth track record
- Debt-to-equity ratio of 0.36 is conservative for a capital-intensive chemicals company, providing balance sheet headroom for expansion
- TTM sales growth of 13% shows top-line momentum is returning, aligned with the company's long-term growth rate
- ROCE of 14.64% indicates the company generates reasonable returns on deployed capital despite a cyclical downturn in recent years
- 10-year stock CAGR of 20% reflects long-term wealth creation even as near-term returns have been subdued
- Trading at ₹2,358.6, approximately 25% below the 52-week high of ₹3,143, and only 8% above the 52-week low of ₹2,178.3, the stock is near the lower end of its recent range
- 5-year compounded sales CAGR of 13% and profit CAGR of 10% show the business has scaled meaningfully over a medium-term horizon
- P/B ratio of 4.57x (flagged at 5.09x on book value basis) is high, suggesting the stock prices in significant future growth
- 3-year ROE of only 12% is below the 10-year average of 17%, indicating returns have structurally deteriorated in the recent cycle
- Stock has delivered a -23% return over the past 1 year and only 3% CAGR over 3 years, significantly underperforming the broader market
- 3-year compounded profit CAGR of -4% shows earnings actually declined over the medium term before the recent TTM recovery
- Dividend yield of just 0.21% offers negligible income support to shareholders during periods of price weakness
- Potential capitalisation of interest costs, as flagged, could mean reported profits overstate true operating earnings and asset values may be inflated
- Last year ROE of 14% and current ROE of 13.07% remain below the 5-year average of 16%, suggesting the recovery in return ratios is still incomplete
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: SRF delivered strong YoY growth in Q2 with 31% profit and 35% revenue gains, but the market punished the stock for a margin miss as EBITDA hit an eight-quarter low of 19.3%. The ₹600 crore battery foil capex and chemical revenue tracking the upper end of FY27 guidance signal long-term growth ambitions. Key risk remains margin compression and sequential weakness; the trend hinges on whether H2 specialty chemicals recovery and new capacity ramp-ups can restore operating leverage.
- EBITDA margin at eight-quarter low Oct 21
EBITDA margin narrowed 200 bps YoY to 19.3% in Q2, an eight-quarter low. EBITDA of ₹946 crore missed street estimates of ₹1,055 crore.
- Stock drops 6.5% post results Oct 21
Shares fell as much as 6.5% on weak operating performance, settling 5.22% lower at ₹2,305. The stock has declined 25% year-to-date.
- Sequential revenue and profit decline Oct 21
Q2 consolidated revenue and net profit declined sequentially from Q1, and H1 operating cash flow fell YoY despite margin improvement.
- ₹600 crore battery foil investment Oct 21
Board approved ₹600 crore capex via subsidiary SRF Altech for a 12,000 MTPA battery-grade aluminium foil plant in Madhya Pradesh, in two ₹300 crore phases completing Sep 2028 and Sep 2030.
- Strong YoY revenue and profit growth Oct 21
Q2 net profit grew 31.2% YoY to ₹509 crore and revenue rose 34.7% to ₹4,904 crore, beating revenue estimates of ₹4,695 crore.
- Performance Films surges 51% Oct 21
Performance Films & Foil business reported 51% topline growth to ₹2,122 crore with 73% operating profit growth to ₹206 crore in Q2.
- Gopalpur HFO commissioning in Q4FY28 Oct 22
Regulatory approvals secured for the Gopalpur HFO project with facility commissioning targeted for Q4FY28.
- Inventory buildup moderates demand Oct 21
Performance Films demand was moderated by inventory build-up following heightened buying activity amid prior-quarter volatility, though aluminium foil demand remained healthy.
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,338 | 3,177 | 3,053 | 3,570 | 3,464 | 3,424 | 3,491 | 4,313 | 3,819 | 3,640 | 3,713 | 4,615 | 5,033 |
| Expenses | 2,642 | 2,551 | 2,487 | 2,874 | 2,861 | 2,886 | 2,872 | 3,356 | 2,989 | 2,866 | 2,933 | 3,589 | 3,797 |
| Operating Profit | 696 | 626 | 566 | 696 | 603 | 538 | 620 | 957 | 830 | 774 | 780 | 1,026 | 1,237 |
| OPM % | 21% | 20% | 19% | 19% | 17% | 16% | 18% | 22% | 22% | 21% | 21% | 22% | 25% |
| Other Income | 12 | 29 | 19 | 23 | 25 | 33 | 40 | 34 | 29 | 26 | −46 | 13 | 34 |
| Interest | 66 | 79 | 67 | 90 | 97 | 94 | 96 | 89 | 80 | 71 | 66 | 62 | 69 |
| Depreciation | 157 | 161 | 169 | 186 | 188 | 194 | 194 | 195 | 203 | 212 | 217 | 220 | 223 |
| PBT | 486 | 415 | 348 | 443 | 344 | 284 | 369 | 707 | 576 | 517 | 452 | 757 | 979 |
| Tax % | 26% | 27% | 27% | 5% | 27% | 29% | 26% | 26% | 25% | 25% | 4% | 23% | 22% |
| Net Profit | 359 | 301 | 253 | 422 | 252 | 201 | 271 | 526 | 432 | 388 | 433 | 582 | 759 |
| EPS (₹) | 12.12 | 10.15 | 8.55 | 14.24 | 8.51 | 6.79 | 9.14 | 17.75 | 14.58 | 13.1 | 14.6 | 19.63 | 25.6 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,540 | 4,593 | 4,822 | 5,589 | 7,100 | 7,209 | 8,400 | 12,434 | 14,870 | 13,139 | 14,693 | 15,787 | 17,001 |
| Expenses | 3,822 | 3,630 | 3,852 | 4,683 | 5,803 | 5,754 | 6,267 | 9,330 | 11,341 | 10,554 | 11,975 | 12,377 | 13,185 |
| Operating Profit | 717 | 963 | 969 | 906 | 1,297 | 1,455 | 2,133 | 3,103 | 3,529 | 2,584 | 2,718 | 3,410 | 3,817 |
| OPM % | 16% | 21% | 20% | 16% | 18% | 20% | 25% | 25% | 24% | 20% | 18% | 22% | 22% |
| Other Income | 65 | 28 | 73 | 115 | 78 | 152 | 66 | 116 | 75 | 83 | 133 | 22 | 27 |
| Interest | 138 | 130 | 102 | 124 | 198 | 201 | 134 | 116 | 205 | 302 | 376 | 278 | 267 |
| Depreciation | 245 | 275 | 283 | 316 | 358 | 389 | 453 | 517 | 575 | 673 | 772 | 852 | 872 |
| PBT | 399 | 585 | 657 | 582 | 818 | 1,018 | 1,612 | 2,586 | 2,824 | 1,692 | 1,704 | 2,302 | 2,705 |
| Tax % | 24% | 27% | 22% | 21% | 22% | 0% | 26% | 27% | 23% | 21% | 27% | 20% | — |
| Net Profit | 303 | 430 | 515 | 462 | 642 | 1,019 | 1,198 | 1,889 | 2,162 | 1,336 | 1,251 | 1,835 | 2,162 |
| EPS (₹) | 10.55 | 14.97 | 17.94 | 16.08 | 22.33 | 35.46 | 40.44 | 63.72 | 72.95 | 45.06 | 42.2 | 61.91 | 72.93 |
| Div. Payout % | 19% | 14% | 14% | 15% | 11% | 8% | 12% | 26% | 10% | 16% | 17% | 15% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 58 | 58 | 58 | 58 | 58 | 58 | 60 | 297 | 297 | 297 | 297 | 297 |
| Reserves | 2,238 | 2,705 | 3,124 | 3,506 | 4,071 | 4,875 | 6,796 | 8,268 | 10,030 | 11,182 | 12,329 | 13,745 |
| Borrowings | 2,435 | 2,515 | 2,396 | 3,142 | 3,730 | 4,135 | 3,469 | 3,655 | 4,478 | 5,031 | 4,726 | 5,083 |
| Other Liabilities | 1,152 | 1,146 | 1,389 | 1,657 | 2,028 | 1,795 | 2,586 | 3,544 | 3,931 | 3,945 | 4,169 | 4,971 |
| Total Liabilities | 5,883 | 6,424 | 6,968 | 8,363 | 9,888 | 10,862 | 12,911 | 15,765 | 18,736 | 20,454 | 21,521 | 24,097 |
| Fixed Assets | 3,922 | 4,113 | 4,405 | 5,122 | 5,609 | 6,368 | 7,827 | 8,425 | 10,050 | 13,242 | 13,720 | 13,926 |
| CWIP | 104 | 117 | 259 | 559 | 754 | 1,393 | 772 | 1,672 | 2,406 | 805 | 811 | 1,889 |
| Investments | 94 | 165 | 196 | 122 | 101 | 203 | 417 | 321 | 494 | 527 | 827 | 687 |
| Other Assets | 1,762 | 2,029 | 2,109 | 2,561 | 3,424 | 2,899 | 3,895 | 5,347 | 5,786 | 5,881 | 6,163 | 7,594 |
| Total Assets | 5,883 | 6,424 | 6,968 | 8,363 | 9,888 | 10,862 | 12,911 | 15,765 | 18,736 | 20,454 | 21,521 | 24,097 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 542 | 1,090 | 645 | 678 | 896 | 1,304 | 1,772 | 2,106 | 2,902 | 2,094 | 2,487 | 2,554 |
| Investing | −500 | −667 | −613 | −1,174 | −1,039 | −1,179 | −1,499 | −1,586 | −2,964 | −2,231 | −1,482 | −1,589 |
| Financing | −18 | −182 | −284 | 495 | 246 | −199 | −251 | −207 | 220 | −72 | −1,071 | −708 |
| Net Cash Flow | 24 | 241 | −252 | −1 | 103 | −73 | 22 | 312 | 158 | −209 | −65 | 256 |
| Free Cash Flow | 58 | 511 | 5 | −605 | −157 | −69 | 567 | 289 | 50 | −108 | 1,265 | 747 |
| CFO/EBITDA | 87 | 125 | 79 | 88 | 81 | 99 | 95 | 81 | 97 | 96 | 104 | 90 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 49 | 41 | 50 | 44 | 53 | 45 | 55 | 53 | 44 | 54 | 54 | 59 |
| Inventory Days | 110 | 105 | 126 | 115 | 113 | 119 | 133 | 129 | 112 | 127 | 111 | 131 |
| Days Payable | 83 | 112 | 122 | 126 | 127 | 110 | 144 | 126 | 110 | 120 | 111 | 121 |
| Cash Conversion Cycle | 75 | 34 | 54 | 34 | 38 | 54 | 45 | 55 | 46 | 61 | 55 | 69 |
| Working Capital Days | 10 | 1 | −15 | −21 | −17 | −37 | −14 | 1 | −6 | −18 | −9 | −12 |
| ROCE % | 11% | 14% | 14% | 11% | 14% | 14% | 18% | 24% | 22% | 13% | 12% | 15% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view SRF insights
63 extracted metrics across FY11–FY27.
Documents
- Q1 FY27 concall · Jul 2026Transcript PPT Recording
- Q4 FY26 concall · May 2026Transcript PPT
- Q3 FY26 concall · Jan 2026Transcript PPT Recording
- Q2 FY26 concall · Nov 2025Transcript PPT Recording
- Concall · Sep 2025Transcript Recording
- 28 Sep 2026
- 10 Jun 2026
- 21 May 2026
- 11 Jun 2025
- 21 May 2025
Frequently Asked Questions about SRF
What does SRF Ltd do?
Where is SRF Ltd (SRF) listed?
Which sector does SRF Ltd belong to?
What is the PE ratio of SRF Ltd?
What is the 52-week high and low of SRF Ltd?
Does SRF Ltd pay dividends?
What is the Return on Equity (ROE) of SRF Ltd?
Company Information
Incorporated in 1970, SRF Ltd manufactures and sells technical textiles, chemicals, packaging films, aluminum foils, and other polymers
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SRF.md for SRF Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.